Brooke N. Bullock

Assessing Helical Protein Interfaces for Inhibitor Design

Brooke N. Bullock, Andrea L. Jochim, Paramjit S. Arora · Journal of the American Chemical Society · 2011 · 294 citations · Full text

Life Sciences, Biochemistry, Medicinal Chemistry +17

Targeting HPV16 E6-p300 interaction reactivates p53 and inhibits the tumorigenicity of HPV-positive head and neck squamous cell carcinoma

Xin Xie, Longzhen Piao, Brooke N. Bullock et al. · Oncogene · 2013 · 81 citations

Medicine, Molecular Biology, Oncology +15

Historical changes in the distributions of invasive and endemic marine invertebrates are contrary to global warming predictions: the effects of decadal climate oscillations

Thomas J. Hilbish, Pamela M. Brannock, Karlie Jones et al. · Journal of Biogeography · 2009 · 80 citations

Life Sciences, Biology, Ecology +16

Adding Diverse Noncanonical Backbones to Rosetta: Enabling Peptidomimetic Design

Kevin Drew, P. Douglas Renfrew, Timothy W. Craven et al. · PLoS ONE · 2013 · 74 citations · Full text

Pharmacy, Biochemistry, Medicinal Chemistry +17

Plucking the high hanging fruit: A systematic approach for targeting protein–protein interactions

Monika Raj, Brooke N. Bullock, Paramjit S. Arora · Bioorganic & Medicinal Chemistry · 2012 · 64 citations · Full text

Life Sciences, Biochemistry, Biotechnology +11